The long awaited House of Lords ruling concerning the ownership of a chemical immunology patent has issued. The technology in question was developed at Weizman but patented by Rorer, on behalf of Schlessinger, an inventor working for Rorer whilst on Sabbatical.
For the full story, see the (London) Times article:
http://business.timesonline.co.uk/tol/business/law/reports/article2767162.ece
This entry was posted on Tuesday, October 30th, 2007 at 9:28 pm and is filed under Intellectual Property, Israel, Israel Related, Patents, UK Patent, UKIPO, UKPTO, pharmaceuticals, pharmaceuticals and Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
Dr. Michael Factor is an Israel Patent Attorney and partner of JMB, Factor & Co. Israel's International IP Firm.
Theme Contempt by Vault9.
Blog at WordPress.com.
